LONDON--(BUSINESS WIRE)--Global breast biopsy devices market will grow by USD 504.94 million during 2020-2024. Amid the COVID-19 pandemic the global breast biopsy devices market registered a YOY ...

Rising incidence of breast cancer, growing adoption of breast-conserving surgeries, and increasing demand for minimally invasive and radiation-free localization technologies are the major factors ...

Merit Medical Systems, Inc. MMSI recently received FDA clearance for the SCOUT Bx Delivery System — the first wire-free breast localization solution that can be placed at the time of stereotactic or ...

Cairn Surgical announced its pivotal trial met its primary endpoint, and reported a lower positive margin rate and reduced ...

DUBLIN--(BUSINESS WIRE)--The "Breast Imaging Device Market Size, Outlook and Growth Opportunities, 2019- 2025" report has been added to ResearchAndMarkets.com's offering. The 'Breast Imaging Device ...

Newark, NJ, July 23, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global breast lesion localization market is expected to grow from USD 280 million in 2019 to USD 416.85 ...

South Jordan, UT-based Merit Medical Systems has acquired View Point Medical through a deal worth about $140 million. Carlsbad, CA-based View Point manufactures the OneMark detection imaging system ...

Reviewed by Eleonora Teplinsky, MD, Head of Breast Medical Oncology at Valley Health System in Paramus, New Jersey, Clinical Assistant Professor at Icahn School of Medicine at Mount Sinai in New York ...

NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery of stage 1, HR+, HER2-, RS ≤18 breast cancer. This is an ASCO Meeting Abstract ...